Racial disparities in an aging population: The relationship between age and race in the management of African American men with high-risk prostate cancer

Journal of Geriatric Oncology

Volumn 5, Issue 4, 2014, Pages 352-358

  Mahal, Brandon A ^a   Ziehr, David R ^a   Aizer, Ayal A ^b   Hyatt, Andrew S ^a   Lago Hernandez, Carlos ^a   Choueiri, Toni K ^a   Elfiky, Aymen A ^a   Hu, Jim C ^c   Sweeney, Christopher J ^a   Beard, Clair J ^a   D'Amico, Anthony V ^a   Martin, Neil E ^a   Kim, Simon P ^d   Lathan, Christopher S ^a   Trinh, Quoc Dien ^a   Nguyen, Paul L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD RADIATION ONCOLOGY PROGRAM   (United States)

^c UCLA MEDICAL CENTER   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

African American; Geriatrics; Healthcare disparities; Population health; Prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AFRICAN AMERICAN; AGE; AGED; AGING; ARTICLE; BRACHYTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER THERAPY; CAUCASIAN; CLINICAL EVALUATION; DISEASE ASSOCIATION; EXTERNAL BEAM RADIOTHERAPY; GLEASON SCORE; HEALTH CARE DISPARITY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PROSTATE CANCER; PROSTATECTOMY; RACE DIFFERENCE; EPIDEMIOLOGY; ETHNOLOGY; GERIATRIC ASSESSMENT; HEALTH DISPARITY; MINORITY HEALTH; PROCEDURES; PROSTATIC NEOPLASMS; RISK FACTOR; STATISTICS AND NUMERICAL DATA; UNITED STATES;

AFRICAN AMERICANS; AGE FACTORS; AGED; EUROPEAN CONTINENTAL ANCESTRY GROUP; GERIATRIC ASSESSMENT; HEALTH STATUS DISPARITIES; HUMANS; MALE; MINORITY HEALTH; PROSTATIC NEOPLASMS; RISK FACTORS; SEER PROGRAM; UNITED STATES;

EID: 84908227536     PISSN: 18794068     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jgo.2014.05.001     Document Type: Article

References (37)

1. Siegel R., Ma J., Zou Z., Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014, 64(1):9-29. [Epub 2014/01/09].
2. Administration on Aging (AOA) A Profile of Older Americans: 2011 Available at:, [Accessed 6 February 2014]. http://www.aoa.gov/AoAroot/Aging_Statistics/Profile/2011/4.aspx.
3. Moyer V.A. Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2012, 157(2):120-134.
4. Partin A.W., Kattan M.W., Subong E.N., Walsh P.C., Wojno K.J., Oesterling J.E., et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. JAMA 1997, 277(18):1445-1451. [Epub 1997/05/14].
5. D'Amico A.V., Whittington R., Malkowicz S.B., Schultz D., Blank K., Broderick G.A., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998, 280(11):969-974. [Epub 1998/09/28].
6. NCCN Clinical Practice Guidelines in Oncology. Prostate Cancer 2014, [Available at: http://www.nccn.org. Accessed 30 December 2013].
7. Bill-Axelson A., Holmberg L., Ruutu M., Garmo H., Stark J.R., Busch C., et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2011, 364(18):1708-1717. [Epub 2011/05/06].
8. Wilt T.J., Brawer M.K., Jones K.M., Barry M.J., Aronson W.J., Fox S., et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med 2012, 367(3):203-213. [Epub 2012/07/20].
9. Warde P., Mason M., Ding K., Kirkbride P., Brundage M., Cowan R., et al. Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial. Lancet 2011, 378(9809):2104-2111. [Epub 2011/11/08].
10. Widmark A., Klepp O., Solberg A., Damber J.E., Angelsen A., Fransson P., et al. Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase III trial. Lancet 2009, 373(9660):301-308. [Epub 2008/12/19].
11. D'Amico A.V., Chen M.H., Renshaw A.A., Loffredo M., Kantoff P.W. Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial. JAMA 2008, 299(3):289-295. [Epub 2008/01/24].
12. Jones C.U., Hunt D., McGowan D.G., Amin M.B., Chetner M.P., Bruner D.W., et al. Radiotherapy and short-term androgen deprivation for localized prostate cancer. N Engl J Med 2011, 365(2):107-118. [Epub 2011/07/15].
13. Bechis S.K., Carroll P.R., Cooperberg M.R. Impact of age at diagnosis on prostate cancer treatment and survival. J Clin Oncol 2011, 29(2):235-241. [Epub 2010/12/08].
14. de Camargo Cancela M., Comber H., Sharp L. Age remains the major predictor of curative treatment non-receipt for localised prostate cancer: a population-based study. Br J Cancer 2013, 109(1):272-279. [Epub 2013/06/01].
15. Alibhai S.M., Krahn M.D., Cohen M.M., Fleshner N.E., Tomlinson G.A., Naglie G. Is there age bias in the treatment of localized prostate carcinoma?. Cancer 2004, 100(1):72-81. [Epub 2003/12/24].
16. Fleshner N., Rakovitch E., Klotz L. Differences between urologists in the United States and Canada in the approach to prostate cancer. J Urol 2000, 163(5):1461-1466. [Epub 2001/02/07].
17. Yan Y., Carvalhal G.F., Catalona W.J., Young J.D. Primary treatment choices for men with clinically localized prostate carcinoma detected by screening. Cancer 2000, 88(5):1122-1130. [Epub 2000/03/04].
18. Alibhai S.M., Naglie G., Nam R., Trachtenberg J., Krahn M.D. Do older men benefit from curative therapy of localized prostate cancer?. J Clin Oncol 2003, 21(17):3318-3327. [Epub 2003/08/30].
19. Underwood W., De Monner S., Ubel P., Fagerlin A., Sanda M.G., Wei J.T. Racial/ethnic disparities in the treatment of localized/regional prostate cancer. J Urol 2004, 171(4):1504-1507. [Epub 2004/03/17].
20. Stokes W.A., Hendrix L.H., Royce T.J., Allen I.M., Godley P.A., Wang A.Z., et al. Racial differences in time from prostate cancer diagnosis to treatment initiation: a population-based study. Cancer 2013, 119(13):2486-2493. [Epub 2013/05/30].
21. Presley C.J., Raldow A.C., Cramer L.D., Soulos P.R., Long J.B., Yu J.B., et al. A new approach to understanding racial disparities in prostate cancer treatment. J Geriatr Oncol 2013, 4(1):1-8. [Epub 2013/07/06].
22. Surveillance, Epidemiology, and End Results (SEER) Program: Research Data (1973-2010). National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, based on November 2012 SEER data submission, posted to the SEER web site April 2013, [www.seer.cancer.gov].
23. United States Department of Agriculture Rural-urban Continuum Codes [online database] Available at:, [Accessed 27 December 2013]. http://www.ers.usda.gov/data-products/rural-urban-continuum-codes.aspx.
24. United States Census Bureau. Census 2000 Gateway [online database] Available at:, [Accessed 27 December 2013]. http://www.census.gov/main/www/cen2000html.
25. Fine J., Gray R. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999, 94:496-509.
26. Halbert C.H., Weathers B., Delmoor E., Mahler B., Coyne J., Thompson H.S., et al. Racial differences in medical mistrust among men diagnosed with prostate cancer. Cancer 2009, 115(11):25553-25561. [Epub 2009/11/01].
27. Hamilton R.J., Aronson W.J., Presti J.C., Terris M.K., Kane C.J., Amling C.L., et al. Race, biochemical disease recurrence, and prostate-specific antigen doubling time after radical prostatectomy: results from the SEARCH database. Cancer 2007, 110(10):2202-2209. [Epub 2007/09/19].
28. Barocas D.A., Gray D.T., Fowke J.H., Mercaldo N.D., Blume J.D., Chang S.S., et al. Racial variation in the quality of surgical care for prostate cancer. J Urol 2012, 188(4):1279-1285. [Epub 2012/08/21].
29. Barocas D.A., Grubb R., Black A., Penson D.F., Fowke J.H., Andriole G., et al. Association between race and follow-up diagnostic care after a positive prostate cancer screening test in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer 2013, 119(12):2223-2229. [Epub 2013/04/06].
30. Ryoo J.J., Ordin D.L., Antonio A.L., Oishi S.M., Gould M.K., Asch S.M., et al. Patient preference and contraindications in measuring quality of care: what do administrative data miss?. J Clin Oncol 2013, 31(21):2716-2723. [Epub 2013/6/10].
31. Oshima Lee E., Emanuel E.J. Shared decision making to improve care and reduce costs. N Engl J Med 2013, 368(1):6-8. [Epub 2013/01/04].
32. Gorin S.S., Badr H., Krebs P., Prabhu Das I. Multilevel interventions and racial/ethnic health disparities. J Natl Cancer Inst Monogr 2012, 2012(44):100-111. [Epub 2012/05/25].
33. Ellis S.D., Blackard B., Carpenter W.R., Mishel M., Chen R.C., Godley P.A. Receipt of National Comprehensive Cancer Network guideline-concordant prostate cancer care among African American and Caucasian American men in North Carolina. Cancer 2013, 119(12):2282-2290. [Epub 2013/04/10].
34. Bohac G.C., Guaqueta D., Cheng D.M., Aschengrau A., Hartshorn K.L. Disparity in the use of combined modality therapy for rectal cancer in the older adult. J Geriatr Oncol 2013, 4(1):90-97. [Epub 2013/09/28].
35. Murthy V.H., Krumholz H.M., Gross C.P. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 2004, 291(22):2720-2726. [Epub 2004/06/10].
36. Panjari M., Robinson P.J., Davis S.R., Schwarz M., Bell R.J. A comparison of the characteristics, treatment and outcome after 5years, of Australian women aged 70+ with those aged <70years at the time of diagnosis of breast cancer. J Geriatr Oncol 2014, 5(2):141-147. [Epub 2014/02/06].
37. Pollack C.E., Bekelman J.E., Epstein A.J., Liao K., Wong Y.N., Armstrong K. Racial disparities in changing to a high-volume urologist among men with localized prostate cancer. Med Care 2011, 49(11):999-1006. [Epub 2011/10/19].